Global Immunoassay-Gamma Counters Market, By Product Type (Automated, Manual/ Semi-Automated), Well (Multi-well, Single-well), Application (Radio Immunoassays, Nuclear Medicine Assays, Others), Disease Condition (Cancer Biomarker, Infectious Diseases, Therapeutic Drug Monitoring, Endocrine Hormones, Allergy, Neonatal Screening, Cardiac Markers, Auto-Immune Disease, Others), Purchase Mode (Out-right Purchase, Rental Purchase), End User (Laboratory, Hospitals, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Blood Banks, Others), Distribution Channel (Direct Tender, Third Party Distributors) – Industry Trends and Forecast to 2031.
Immunoassay-Gamma Counters Market Analysis and Size
Growing research and development expenditures, increasing healthcare expenditures, and rising patient awareness towards chronic disease treatment are expected to provide a lucrative growth opportunity for the market. However, the high cost of gamma counters and the risk of gamma radiation are the factors expected to restrain the market growth.
The demand for the immunoassay-gamma counters market has increased in both developed and developing countries, and the reason behind this is an increase in global healthcare expenditure. The immunoassay-gamma counters market is growing due to increased approval of advanced technological products and increased government support.
Data Bridge Market Research analyzes that the global immunoassay-gamma counters market was valued at USD 2,258.28 million in 2023 and is expected to reach USD 3,673.10 million by 2031, registering a CAGR of 6.4%. “Biotechnology companies” accounts for the largest end user segment in the respective market due to the high demand for minimally aesthetic procedures among people. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2021 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Product Type (Automated, Manual/ Semi-Automated), Well (Multi-well, Single-well), Application (Radio Immunoassays, Nuclear Medicine Assays, Others), Disease Condition (Cancer Biomarker, Infectious Diseases, Therapeutic Drug Monitoring, Endocrine Hormones, Allergy, Neonatal Screening, Cardiac Markers, Auto Immune Disease, Others), Purchase Mode (Out-right Purchase, Rental Purchase), End User (Laboratory, Hospitals, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Blood Banks, Others), Distribution Channel (Direct Tender, Third Party Distributors)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Kuwait, Egypt and Rest of Middle East and Africa
|
|
Market Players Covered
|
Hidex Oy (Finland), Perkin Elmer Inc (U.S.), Berthold Technologies GmbH & Co. KG (Germany), ENERSYS Co. Ltd (U.S.), Shinjin Medics Inc (South Korea), and LabLogic Systems Ltd (U.K.)
|
|
Market Opportunities
|
|
Market Definition
An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. The biochemical test is carried out through a device known as “Gamma Counter”. A gamma counter is an instrument to measure gamma radiation emitted by a radionuclide. Unlike survey meters, gamma counters are designed to measure small samples of radioactive material, typically with automated measurement and movement of multiple samples.
Global Immunoassay-Gamma Counters Market Dynamics
Drivers
- Technological Advancements
Advances in endoscopic technology, including improvements in imaging quality, miniaturization of devices, and the development of therapeutic accessories, can enhance the effectiveness and safety of ERCP procedures. Continued innovation in this field may attract healthcare providers to invest in the latest devices.
- Increasing Awareness and Early Diagnosis
Public awareness of gastrointestinal diseases and the importance of early diagnosis have been on the rise. As a result, there is a growing emphasis on preventive healthcare and early detection, leading to an increased demand for diagnostic procedures like ERCP.
- Rising Healthcare Expenditure
The overall increase in healthcare spending, especially in emerging economies, has contributed to the adoption of advanced medical technologies, including endoscopic devices. As healthcare infrastructure improves, there is a greater capacity for hospitals and clinics to invest in modern medical equipment.
Opportunity
- Rising Awareness and Healthcare Infrastructure
Increased awareness among both healthcare professionals and patients about the availability of advanced diagnostic and treatment options may contribute to the growth of the ERCP devices market. Improvements in healthcare infrastructure in developing regions may also play a role.
Restraint/Challenge
- Cost of Procedures and Devices
The cost associated with ERCP procedures and devices can be a significant factor limiting their widespread adoption, particularly in regions with limited healthcare budgets or where reimbursement policies are restrictive.
- Availability of Alternative Diagnostic and Therapeutic Options
In some cases, alternative non-invasive or minimally invasive procedures may be preferred over ERCP, which could limit the growth of the market. For example, magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS) are alternative imaging modalities.
This immunoassay-gamma counters market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunoassay-gamma counters market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2021, PerkinElmer Inc. announced that the company is further looking to expand their footprints in India by relying on innovative products. The new products will be launched in various streams such as science, pharma, and food testing. This has helped the company to expand its Global presence
- In March 2021, Hidex Oy announced its Gamma Counter product is now upgraded with the a sample QR reader and it is offer sample identification and is comply under FDA 21 Part 11 environment. This is expected to increase the demand for the product in the forecasted period and will increase the efficacy of the instrument
- In November 2020, Berthold Technologies GmbH & C0.KG announced that the partial lockdown was ordered to reduce infection rate. However, the company assured to the customers about the reliable delivery as they keep up the production during this time, following the proper guidelines by the government. This helps the company to maintain the demand and generate revenue during the pandemic
Global Immunoassay-Gamma Counters Market Scope
The immunoassay-gamma counters market is segmented on the basis of product type, application, and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Automated
- Manual/ Semi-Automated
Well
- Multi-well
- Single-well
Application
- Radio Immunoassays
- Nuclear Medicine Assays
- Others
Disease Condition
- Cancer Biomarker
- Infectious Diseases
- Therapeutic Drug Monitoring
- Endocrine Hormones
- Allergy
- Neonatal Screening
- Cardiac Markers
- Auto Immune Disease
- Others
Purchase Mode
- Out-right Purchase
- Rental Purchase
End User
- Laboratory
- Hospitals
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Blood Banks
- Others
Distribution Channel
- Direct Tender
- Third Party Distributors
Global Immunoassay-Gamma Counters Market Regional Analysis/Insights
The immunoassay-gamma counters market is analyzed and market size information is provided on the basis of country, product type, well, application, disease condition, purchase mode, end user, and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Belgium, Georgia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and rest of Middle East and Africa.
Asia-Pacific is expected to dominate the market due to increased productivity in the automated segment. Europe is expected to fastest growth in the market due to more efficient use of materials.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Product approvals and novelty in diagnosis procedures are boosting the market growth of immunoassay-gamma counters.
Immunoassay-gamma counters market also provides you with detailed market analysis for every country growth in immunoassay-gamma counters industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the immunoassay-gamma counters market. The data is available for historic period 2011 to 2021.
Competitive Landscape and Global Immunoassay-Gamma Counters Market Share Analysis
Immunoassay-gamma counters market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breaath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to immunoassay-gamma counters.
Some of the major players operating in the immunoassay-gamma counters market are:
- Hidex Oy (Finland)
- PerkinElmer Inc (U.S.)
- Berthold Technologies GmbH & Co. KG (Germany)
- ENERSYS Co. Ltd (Japan)
- Shinjin Medics Inc (South Korea)
- LabLogic Systems Ltd (U.K.)
SKU-